Stocks
ALX Oncology Holdings (ALXO) EV/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EV/EBITDA | ? | 0.19 | -69.0 | -6.03 | -1.53 | -3.00 | -1.80 | |
| Changes by years, y/y, % | -69% | -36 114% | -91% | -75% | +96% | |||
ALX Oncology Holdings. EV/EBITDA
ALX Oncology Holdings. EV/EBITDA, changes, %
ALX Oncology Holdings (ALXO) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -0.07 | -3.56 | -2.55 | -1.03 | 0.29 | -1.80 | |
| Changes by years, y/y, % | -88% | +142% | -1 127% | +31% | -495% | |||
| Changes by quarters, q/q, % | -91% | +4 778% | -28% | -60% | -128% | |||
